Establishing Value, Access and Positive Outcomes

Patient Support Programs have emerged as a critical component in the path to market access.  As the locus where patient adherence is supported and RWE is gathered, they are important to establishing the value and potential of new targeted therapies.  Adopt best practices to:

• Analyze the evolving role of PSPs in gathering data for use as RWE and to address health equity challenges across provinces
• Strengthen the collaboration between PSPs, patient advocacy groups and HTA bodies to establish value to the patient
• Link patient-reported outcomes (PROs) to long-term funding agreements to ensure therapies are delivering on what was promised.
• Collate and provide data to support the patient experience and report any adverse effects.

Learn how to effectively leverage data generated through PSPs to gather RWE, establish value for patients and support equitable access.